Sprycel^® (dasatinib) is a prescription medication used in the treatment of chronic myeloid leukemia and acute lymphoblastic leukemia. At this time, it is unknown if this medication passes through human breast milk. If you are breastfeeding or planning to start, talk to your healthcare provider before taking Sprycel.

More Information About Sprycel and Breastfeeding

Sprycel has not been studied in women who are breastfeeding. Therefore, it is unknown if the drug passes through human breast milk, or if it would harm a nursing infant. Based on the properties of the drug, it is expected to pass through breast milk to some extent; however, probably not in large amounts.

Sprycel is associated with potentially serious side effects. Because of the potential for these side effects in a nursing infant, the manufacturer of the medication recommends women either choose to breastfeed or use the drug, but not to do both.

If your healthcare provider recommends breastfeeding while using Sprycel, be watchful for any problems in your child. Contact your child's healthcare provider if you notice any possible Sprycel side effects, including but not limited to:

Fever
Diarrhea
Excessive sleeping
Excessive crying
Difficulty breathing
Problems feeding.

Sprycel and Breastfeeding Article Continues on Next Page >

Sprycel Medication Information

List of references (click here)

Written by/reviewed by: Susan Lakey, PharmD, MPH, BCPP

Last reviewed by: Kristi Monson, PharmD

Sprycel Drug Interactions

Sprycel Warnings and Precautions

Sprycel Overdose

Sprycel and Pregnancy

Sprycel and Breastfeeding

Generic Sprycel

Referring Pages:

Articles

Advertise with Us

About eMedTV

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.